Literature DB >> 33020658

Non-animal-derived monoclonal antibodies are not ready to substitute current hybridoma technology.

África González-Fernández1, Francisco J Bermúdez Silva2, Marcos López-Hoyos3, César Cobaleda4, Lluís Montoliu5, Margarita Del Val6, Kirk Leech7.   

Abstract

Year:  2020        PMID： 33020658     DOI： 10.1038/s41592-020-00977-5

Source DB:  PubMed          Journal:  Nat Methods        ISSN： 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  3 in total

1.  AAPS Perspective on the EURL Recommendation on the use of Non-Animal-Derived Antibodies.

Authors:  B Gorovits; A Hays; D Jani; C Jones; C King; A Lundequist; J Mora; M Partridge; D Pathania; S S Ramaswamy; D Rutwij; H Shen; G Starling
Journal:  AAPS J       Date:  2021-03-01       Impact factor: 4.009

Review 2.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

3.  Animal- versus in vitro-derived antibodies: avoiding the extremes.

Authors:  Andrew R M Bradbury; Stefan Dübel; Achim Knappik; Andreas Plückthun
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.